Screener
Ionis Pharmaceuticals IONS Ionis Operations — Manufacturing And Development Chemistry Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:ManufacturingAndDevelopmentChemistryExpenses.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Drug discovery | 29,120 | 30,255 | 57,677 | 57,244 |
| Drug development | 103,958 | 117,689 | 208,140 | 230,635 |
| Medical affairs | 11,318 | 7,826 | 21,307 | 13,468 |
| Manufacturing and development chemistry | 20,639 | 21,545 | 40,947 | 35,826 |
| R&D support | 26,974 | 20,607 | 49,405 | 41,159 |
| Selling, general and administrative | 130,075 | 81,081 | 262,012 | 148,061 |
| Other segment items (1) | 57,948 | 45,954 | 76,330 | 75,750 |
| Consolidated net income (loss) | $$(114,646) | $123,551 | $(207,174) | (23,387) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses?
- Ionis Pharmaceuticals (IONS) reported ionis operations — manufacturing and development chemistry expenses of $20.64M in Q2 2026.
- How has Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses changed year-over-year?
- Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses decreased by 4.2% year-over-year, from $21.55M to $20.64M.
- What is the long-term trend for Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses has grown at a 4.7% compound annual growth rate (CAGR), from $76.16M to $87.31M.
- What does ionis operations — manufacturing and development chemistry expenses mean?
- This encompasses the costs of process chemistry, scale-up, and manufacturing development required to produce drug substances for clinical trials and commercial use. It bridges the gap between laboratory discovery and large-scale commercial manufacturing.
Ask your AI about Ionis Pharmaceuticals's ionis operations — manufacturing and development chemistry expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude